Nature Medicine, 2024 Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks Perry A., Farber-Eger E., Gonzales T. et al. Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma | | | | |
Epilepsy & Behavior, 2024 Assessing the impact of circulating inflammatory cytokines and proteins as drivers and therapeutic targets in epilepsy: A Mendelian randomization study Wang W., Ma L., Liu M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2024 Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis Snir T, Greenman R, Aricha R et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
New England Journal of Medicine, 2024 The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1 Oikonomou V., Smith G., Constantine G. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
European Heart Journal: Acute Cardiovascular Care, 2024 Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit Patel S., Lopes M., Morrow D. et al. Olink Target 96CVDPatient StratificationBlood | | | | |
Analytical Chemistry, 2024 Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates Beutgen V., Bhagwat A., Steitz A. et al. Olink Target 96Infectious DiseasesTechnical EvaluationCell Culture Supernatant | | | | |
JAMA Cardiology, 2024 High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life Ramonfaur D., Buckley L., Arthur V. et al. Olink Explore 3072/384CVDAgingCross-platform ValidationPlasma | | | | |
International Journal of Molecular Sciences, 2024 ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19 Sun J., Edsfeldt A., Svensson J. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Journal of Clinical Medicine, 2024 A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research Menéndez-Valladares P., Acevedo Aguilera R., Núñez-Jurado D. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Nature Aging, 2024 A plasma protein-based risk score to predict hip fractures Austin T., Nethander M., Fink H. et al. Olink Explore 3072/384AgingPatient StratificationPlasma | | | | |
Movement Disorders, 2024 Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts Khosousi S., Sturchio A., Appleton E. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Archives of Dermatological Research, 2024 Genetic analyses unravel the causal association of cytokine levels on lichen simplex chronicus risk: insights from a mendelian randomization study Yu H., Ou G. Olink Target 96Dermatological DiseasesPathophysiologyPlasma | | | | |
PROTEOMICS, 2024 Capillary blood self‐collection for high‐throughput proteomics El‐Sabawi B., Huang S., Tanriverdi K. et al. Olink Explore 3072/384Wider Proteomics StudiesTechnical EvaluationCapillary BloodBlood | | | | |
Science Translational Medicine, 2024 Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes Chen Z., Satake E., Pezzolesi M. et al. Olink Target 96NephrologyPathophysiologyPatient StratificationPlasma | | | | |
International Journal of Obesity, 2024 Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study Fryk E., Rodrigues Silva V., Strindberg L. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |
International Urology and Nephrology, 2024 Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study Yuan D., Yang J., Wu W. et al. Olink Target 96NephrologyPathophysiologyPlasma | | | | |
Biomedicines, 2024 Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy Song Y., Pan S., Tian J. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma | | | | |
BMC Medical Genomics, 2024 Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis Tan C., Li Y., Wang K. et al. Olink Target 96OncologyCVDPathophysiologyPlasma | | | | |
iScience, 2024 Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior Jansen S., Cutilli A., de Koning C. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Scientific Reports, 2024 The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population Grauen Larsen H., Sun J., Sjögren M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |